 | • レポートコード：B-GIR08C1007 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、癌免疫療法創薬アウトソーシングの世界市場について調べ、まとめました。種類別セグメントは、モノクローナル抗体、免疫調節剤、腫瘍崩壊性ウイルス療法・癌ワクチン、その他等、用途別セグメントは、等に区分しました。癌免疫療法創薬アウトソーシングの世界市場概観、企業動向、企業別癌免疫療法創薬アウトソーシングシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・癌免疫療法創薬アウトソーシングの市場概観 ・癌免疫療法創薬アウトソーシングの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・癌免疫療法創薬アウトソーシングの企業別販売動向、市場シェア、市場集中度、競争動向 ・癌免疫療法創薬アウトソーシングの世界市場規模 ・癌免疫療法創薬アウトソーシングの北米市場分析（アメリカ、カナダ、メキシコ等） ・癌免疫療法創薬アウトソーシングのアメリカ市場規模推移 ・癌免疫療法創薬アウトソーシングのカナダ市場規模推移 ・癌免疫療法創薬アウトソーシングのメキシコ市場規模推移 ・癌免疫療法創薬アウトソーシングのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・癌免疫療法創薬アウトソーシングのドイツ市場規模推移 ・癌免疫療法創薬アウトソーシングのイギリス市場規模推移 ・癌免疫療法創薬アウトソーシングのロシア市場規模推移 ・癌免疫療法創薬アウトソーシングのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・癌免疫療法創薬アウトソーシングの日本市場規模推移 ・癌免疫療法創薬アウトソーシングの中国市場規模推移 ・癌免疫療法創薬アウトソーシングの韓国市場規模推移 ・癌免疫療法創薬アウトソーシングのインド市場規模推移 ・癌免疫療法創薬アウトソーシングの東南アジア市場規模推移 ・癌免疫療法創薬アウトソーシングの南米市場分析（ブラジル、アルゼンチン等） ・癌免疫療法創薬アウトソーシングの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・癌免疫療法創薬アウトソーシングの種類別分析/販売量、売上、市場シェア（モノクローナル抗体、免疫調節剤、腫瘍崩壊性ウイルス療法・癌ワクチン、その他） ・癌免疫療法創薬アウトソーシングの用途別分析/市場規模（） ・癌免疫療法創薬アウトソーシングの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・癌免疫療法創薬アウトソーシングの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Cancer Immunotherapy Drug Discovery Outsourcing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cancer Immunotherapy Drug Discovery Outsourcing.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Cancer Immunotherapy Drug Discovery Outsourcing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Immunotherapy Drug Discovery Outsourcing market by product type and applications/end industries.
Market Segment by Companies, this report covers
Aquila BioMedical
BPS Bioscience, Inc.
Celentyx Ltd
Crown Bioscience, Inc.
DiscoverX Corporation
Explicyte
Genscript Biotech Corporation
HD Biosciences Co.
Horizon Discovery Group PLC
ImmunXperts SA
Molecular Imaging, Inc.
Promega Corporation,Personalis, Inc.
STC Biologics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monoclonal Antibodies
Immunomodulators
Oncolytic Viral Therapies and Cancer Vaccines
Other
Market Segment by Applications, can be divided into
Lung
Breast
Colorectal
Melanoma
Prostate
Head and Neck
Ovarian
Pancreatic
Table of Contents
1 Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
1.1 Product Overview and Scope of Cancer Immunotherapy Drug Discovery Outsourcing
1.2 Classification of Cancer Immunotherapy Drug Discovery Outsourcing by Types
1.2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Comparison by Types (2019-2024)
1.2.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Types in 2018
1.2.3 Monoclonal Antibodies
1.2.4 Immunomodulators
1.2.5 Oncolytic Viral Therapies and Cancer Vaccines
1.2.6 Other
1.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Application
1.3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Lung
1.3.3 Breast
1.3.4 Colorectal
1.3.5 Melanoma
1.3.6 Prostate
1.3.7 Head and Neck
1.3.8 Ovarian
1.3.9 Pancreatic
1.4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Regions
1.4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Cancer Immunotherapy Drug Discovery Outsourcing Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Immunotherapy Drug Discovery Outsourcing Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Immunotherapy Drug Discovery Outsourcing Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Cancer Immunotherapy Drug Discovery Outsourcing Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Immunotherapy Drug Discovery Outsourcing Status and Prospect (2014-2024)
1.5 Global Market Size of Cancer Immunotherapy Drug Discovery Outsourcing (2014-2024)
2 Manufacturers Profiles
2.1 Aquila BioMedical
2.1.1 Business Overview
2.1.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
2.2 BPS Bioscience, Inc.
2.2.1 Business Overview
2.2.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
2.3 Celentyx Ltd
2.3.1 Business Overview
2.3.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
2.4 Crown Bioscience, Inc.
2.4.1 Business Overview
2.4.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
2.5 DiscoverX Corporation
2.5.1 Business Overview
2.5.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
2.6 Explicyte
2.6.1 Business Overview
2.6.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
2.7 Genscript Biotech Corporation
2.7.1 Business Overview
2.7.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
2.8 HD Biosciences Co.
2.8.1 Business Overview
2.8.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
2.9 Horizon Discovery Group PLC
2.9.1 Business Overview
2.9.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
2.10 ImmunXperts SA
2.10.1 Business Overview
2.10.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
2.11 Molecular Imaging, Inc.
2.11.1 Business Overview
2.11.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
2.12 Promega Corporation,Personalis, Inc.
2.12.1 Business Overview
2.12.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
2.13 STC Biologics
2.13.1 Business Overview
2.13.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Competition, by Players
3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Immunotherapy Drug Discovery Outsourcing Players Market Share
3.2.2 Top 10 Cancer Immunotherapy Drug Discovery Outsourcing Players Market Share
3.3 Market Competition Trend
4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions
4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Market Share by Regions
4.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
4.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
4.5 South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
5 North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries
5.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries (2014-2019)
5.2 USA Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
5.3 Canada Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
5.4 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
6 Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries
6.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries (2014-2019)
6.2 Germany Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
6.3 UK Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
6.4 France Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
6.5 Russia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
6.6 Italy Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries
7.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries (2014-2019)
7.2 China Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
7.3 Japan Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
7.4 Korea Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
7.5 India Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
8 South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries
8.1 South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries (2014-2019)
8.2 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
8.3 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
8.4 Colombia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Cancer Immunotherapy Drug Discovery Outsourcing by Countries
9.1 Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries (2014-2019)
9.2 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
9.3 UAE Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
9.4 Egypt Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
9.5 Nigeria Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
9.6 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
10 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Segment by Type
10.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Market Share by Type (2014-2019)
10.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast by Type (2019-2024)
10.3 Monoclonal Antibodies Revenue Growth Rate (2014-2024)
10.4 Immunomodulators Revenue Growth Rate (2014-2024)
10.5 Oncolytic Viral Therapies and Cancer Vaccines Revenue Growth Rate (2014-2024)
10.6 Other Revenue Growth Rate (2014-2024)
11 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Segment by Application
11.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Application (2014-2019)
11.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast by Application (2019-2024)
11.3 Lung Revenue Growth (2014-2019)
11.4 Breast Revenue Growth (2014-2019)
11.5 Colorectal Revenue Growth (2014-2019)
11.6 Melanoma Revenue Growth (2014-2019)
11.7 Prostate Revenue Growth (2014-2019)
11.8 Head and Neck Revenue Growth (2014-2019)
11.9 Ovarian Revenue Growth (2014-2019)
11.10 Pancreatic Revenue Growth (2014-2019)
12 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Forecast (2019-2024)
12.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Forecast (2019-2024)
12.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast by Regions (2019-2024)
12.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2019-2024)
12.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2019-2024)
12.6 South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Cancer Immunotherapy Drug Discovery Outsourcing Picture
Table Product Specifications of Cancer Immunotherapy Drug Discovery Outsourcing
Table Global Cancer Immunotherapy Drug Discovery Outsourcing and Revenue (Million USD) Market Split by Product Type
Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Types in 2018
Figure Monoclonal Antibodies Picture
Figure Immunomodulators Picture
Figure Oncolytic Viral Therapies and Cancer Vaccines Picture
Figure Other Picture
Table Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue (Million USD) by Application (2014-2024)
Figure Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Applications in 2018
Figure Lung Picture
Figure Breast Picture
Figure Colorectal Picture
Figure Melanoma Picture
Figure Prostate Picture
Figure Head and Neck Picture
Figure Ovarian Picture
Figure Pancreatic Picture
Table Global Market Cancer Immunotherapy Drug Discovery Outsourcing Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue (Million USD) and Growth Rate (2014-2024)
Table Aquila BioMedical Basic Information, Manufacturing Base and Competitors
Table Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
Table Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
Table BPS Bioscience, Inc. Basic Information, Manufacturing Base and Competitors
Table BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
Table BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
Table Celentyx Ltd Basic Information, Manufacturing Base and Competitors
Table Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
Table Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
Table Crown Bioscience, Inc. Basic Information, Manufacturing Base and Competitors
Table Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
Table Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
Table DiscoverX Corporation Basic Information, Manufacturing Base and Competitors
Table DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
Table DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
Table Explicyte Basic Information, Manufacturing Base and Competitors
Table Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
Table Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
Table Genscript Biotech Corporation Basic Information, Manufacturing Base and Competitors
Table Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
Table Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
Table HD Biosciences Co. Basic Information, Manufacturing Base and Competitors
Table HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
Table HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
Table Horizon Discovery Group PLC Basic Information, Manufacturing Base and Competitors
Table Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
Table Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
Table ImmunXperts SA Basic Information, Manufacturing Base and Competitors
Table ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
Table ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
Table Molecular Imaging, Inc. Basic Information, Manufacturing Base and Competitors
Table Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
Table Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
Table Promega Corporation,Personalis, Inc. Basic Information, Manufacturing Base and Competitors
Table Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
Table Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
Table STC Biologics Basic Information, Manufacturing Base and Competitors
Table STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
Table STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
Table Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue (Million USD) by Players (2014-2019)
Table Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Players (2014-2019)
Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Players in 2017
Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Players in 2018
Figure Global Top 5 Players Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share in 2018
Figure Global Top 10 Players Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share in 2018
Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue (Million USD) by Regions (2014-2019)
Table Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Regions (2014-2019)
Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Regions (2014-2019)
Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Regions in 2018
Figure North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Table North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries (2014-2019)
Table North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Countries (2014-2019)
Figure North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Countries (2014-2019)
Figure North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Countries in 2018
Figure USA Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure Canada Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure Mexico Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Table Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue (Million USD) by Countries (2014-2019)
Figure Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Countries (2014-2019)
Figure Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Countries in 2018
Figure Germany Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure UK Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure France Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure Russia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure Italy Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Countries in 2018
Figure China Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure Japan Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure Korea Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure India Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Table South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries (2014-2019)
Table South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Countries (2014-2019)
Figure South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Countries (2014-2019)
Figure South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Countries in 2018
Figure Brazil Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure Argentina Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure Colombia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Countries in 2018
Figure Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure UAE Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure Egypt Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure Nigeria Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Figure South Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
Table Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue (Million USD) by Type (2014-2019)
Table Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Type (2014-2019)
Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Type (2014-2019)
Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Type in 2018
Table Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Forecast by Type (2019-2024)
Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share Forecast by Type (2019-2024)
Figure Global Monoclonal Antibodies Revenue Growth Rate (2014-2019)
Figure Global Immunomodulators Revenue Growth Rate (2014-2019)
Figure Global Oncolytic Viral Therapies and Cancer Vaccines Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Application (2014-2019)
Table Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Application (2014-2019)
Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Application (2014-2019)
Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Application in 2018
Table Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Forecast by Application (2019-2024)
Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share Forecast by Application (2019-2024)
Figure Global Lung Revenue Growth Rate (2014-2019)
Figure Global Breast Revenue Growth Rate (2014-2019)
Figure Global Colorectal Revenue Growth Rate (2014-2019)
Figure Global Melanoma Revenue Growth Rate (2014-2019)
Figure Global Prostate Revenue Growth Rate (2014-2019)
Figure Global Head and Neck Revenue Growth Rate (2014-2019)
Figure Global Ovarian Revenue Growth Rate (2014-2019)
Figure Global Pancreatic Revenue Growth Rate (2014-2019)
Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2019-2024)
Figure Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2019-2024)
Figure South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2019-2024)
がん免疫療法の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body's natural defenses to fight cancer. Scope of the Report: The global Cancer Immunotherapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a…- 創薬市場：世界及び中国市場分析・予測（～2024年） Drug Discovery Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Drug Discovery industry with a focus on the Chinese market. The report provides key statistics on the market status of the Drug Discovery manufacturers and is a va…
- 世界の外注創薬市場：市場規模・現状・予測 In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitousdiscovery.In 2018, the global Outsour…
- 世界の小分子創薬市場：市場規模・現状・予測 In 2018, the global Small-Molecule Drug Discovery market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Small-Molecule Drug Discovery status, future forecast, growth opportunity, key market…
- 世界のフラグメントベースの創薬市場：市場規模・現状・予測 In 2018, the global Fragment-based Drug Discovery market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Fragment-based Drug Discovery status, future forecast, growth opportunity, key market and key p…